This work is licensed under the Creative Commons Attribution 4.0 International License.
Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 2021; 14: 101174. doi: 10.1016/j.tranon.2021.101174XiYXuP.Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol2021; 14: 101174. doi: 10.1016/j.tranon.2021.101174Open DOISearch in Google Scholar
Huang P, Feng Z, Shu X, Wu A, Wang Z, Hu T, et al. A bibliometric and visual analysis of publications on artificial intelligence in colorectal cancer (20022022). Front Oncol 2023; 13: 1077539. doi: 10.3389/fonc.2023.1077539HuangPFengZShuXWuAWangZHuTA bibliometric and visual analysis of publications on artificial intelligence in colorectal cancer (20022022). Front Oncol2023; 13: 1077539. doi: 10.3389/fonc.2023.1077539Open DOISearch in Google Scholar
Bizuayehu HM, Dadi AF, Ahmed KY, Tegegne TK, Hassen TA, Kibret GD, et al. Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates. Cancer 2024; 130: 3708-23. doi: 10.1002/cncr.35458BizuayehuHMDadiAFAhmedKYTegegneTKHassenTAKibretGDBurden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates. Cancer2024; 130: 3708-23. doi: 10.1002/cncr.35458Open DOISearch in Google Scholar
Wani HA, Majid S, Bhat AA, Amin S, Farooq R, Bhat SA, et al. Impact of cat-echol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer. Eur J Cancer Prev 2019; 28: 68-75. doi: 10.1097/CEJ.0000000000000485WaniHAMajidSBhatAAAminSFarooqRBhatSAImpact of cat-echol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer. Eur J Cancer Prev2019; 28: 68-75. doi: 10.1097/CEJ.0000000000000485Open DOISearch in Google Scholar
Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 2023; 72: 338-44. doi: 10.1136/gutjnl-2022-327736MorganEArnoldMGiniALorenzoniVCabasagCJLaversanneMGlobal burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut2023; 72: 338-44. doi: 10.1136/gutjnl-2022-327736Open DOISearch in Google Scholar
Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers 2022; 14: 1732. doi: 10.3390/cancers14071732HossainMSKaruniawatiHJairounAAUrbiZOoiJJohnAColorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers2022; 14: 1732. doi: 10.3390/cancers14071732Open DOISearch in Google Scholar
Parmar S, Easwaran H. Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterol Rep 2022; 10: goac035. doi: 10.1093/gastro/goac035ParmarSEaswaranH.Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterol Rep2022; 10: goac035. doi: 10.1093/gastro/goac035Open DOISearch in Google Scholar
Li F, Qasim S, Li D, Dou QP. Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator. Semin Cancer Biol 2022; 83: 335-52. doi: 10.1016/j.semcancer.2020.11.018LiFQasimSLiDDouQP.Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator. Semin Cancer Biol2022; 83: 335-52. doi: 10.1016/j.semcancer.2020.11.018Open DOISearch in Google Scholar
Franko A, Goricar K, Dodic Fikfak M, Kovac V, Dolzan V. The role of polymorphisms in glutathione-related genes in asbestos-related diseases. Radiol Oncol 2021; 55: 179-86. doi: 10.2478/raon-2021-0002FrankoAGoricarKDodic FikfakMKovacVDolzanV.The role of polymorphisms in glutathione-related genes in asbestos-related diseases. Radiol Oncol2021; 55: 179-86. doi: 10.2478/raon-2021-0002Open DOISearch in Google Scholar
Cui J, Li G, Yin J, Li L, Tan Y, Wei H, et al. GSTP1 and cancer: Expression, methylation, polymorphisms and signaling. Int J Oncol 2020; 56: 867-78. doi: 10.3892/ijo.2020.4979CuiJLiGYinJLiLTanYWeiHGSTP1 and cancer: Expression, methylation, polymorphisms and signaling. Int J Oncol2020; 56: 867-78. doi: 10.3892/ijo.2020.4979Open DOISearch in Google Scholar
Gasic V, Zukic B, Stankovic B, Janic D, Dokmanovic L, Lazic J, et al. Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia. Radiol Oncol 2018; 52: 296-306. doi: 10.2478/raon-2018-0034GasicVZukicBStankovicBJanicDDokmanovicLLazicJPharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia. Radiol Oncol2018; 52: 296-306. doi: 10.2478/raon-2018-0034Open DOISearch in Google Scholar
Bartolini D, Torquato P, Piroddi M, Galli F. Targeting glutathione S-transferase P and its interactome with selenium compounds in cancer therapy. Biochim Biophys Acta Gen Subj 2019; 1863: 130-43. doi: 10.1016/j.bba-gen.2018.09.023BartoliniDTorquatoPPiroddiMGalliF.Targeting glutathione S-transferase P and its interactome with selenium compounds in cancer therapy. Biochim Biophys Acta Gen Subj2019; 1863: 130-43. doi: 10.1016/j.bba-gen.2018.09.023Open DOISearch in Google Scholar
Nissar S, Sameer AS, Rasool R, Chowdri N, Rashid F. Glutathione S transferases: biochemistry, polymorphism and role in colorectal carcinogenesis. J Carcinog Mutagen 2017; 8: 287. doi: 10.1007/s12253-019-00589-1NissarSSameerASRasoolRChowdriNRashidF.Glutathione S transferases: biochemistry, polymorphism and role in colorectal carcinogenesis. J Carcinog Mutagen2017; 8: 287. doi: 10.1007/s12253-019-00589-1Open DOISearch in Google Scholar
Wang Q, Wang J, Xiang H, Ding P, Wu T, Ji G. The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers. Am J Cancer Res 2021; 11: 5833. PMID: 35018228WangQWangJXiangHDingPWuTJiG.The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers. Am J Cancer Res2021; 11: 5833. PMID: 35018228Search in Google Scholar
Fusco N, Sajjadi E, Venetis K, Gaudioso G, Lopez G, Corti C, et al. M. PTEN alterations and their role in cancer management: are we making headway on precision medicine? Genes 2020; 11: 719. doi: 10.3390/genes11070719FuscoNSajjadiEVenetisKGaudiosoGLopezGCortiCM. PTEN alterations and their role in cancer management: are we making headway on precision medicine?Genes2020; 11: 719. doi: 10.3390/genes11070719Open DOISearch in Google Scholar
Vodusek AL, Goricar K, Gazic B, Dolzan V, Jazbec J. Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence. Radiol Oncol 2016; 50: 80-6. doi: 10.1515/raon-2015-0026VodusekALGoricarKGazicBDolzanVJazbecJ.Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence. Radiol Oncol2016; 50: 80-6. doi: 10.1515/raon-2015-0026Open DOISearch in Google Scholar
Song DD, Zhang Q, Li JH, Hao RM, Ma Y, Wang PY, et al. Single nucleotide polymorphisms rs701848 and rs2735343 in PTEN increases cancer risks in an Asian population. Oncotarget 2017; 8: 96290. doi: 10.18632/onco-target.22019SongDDZhangQLiJHHaoRMMaYWangPYSingle nucleotide polymorphisms rs701848 and rs2735343 in PTEN increases cancer risks in an Asian population. Oncotarget2017; 8: 96290. doi: 10.18632/onco-target.22019Open DOISearch in Google Scholar
Lemoshow S, Hosmer Jr DW, Klar J, Lewang SK. Adecuacy of Simple size in healt studies. Chichester (England): John Wiley & Sons LTD; 1990.LemoshowSHosmerDWJrKlarJLewangSK.Adecuacy of Simple size in healt studies. Chichester (England): John Wiley & Sons LTD; 1990.Search in Google Scholar
Welfare M, Monesola Adeokun A, Bassendine MF, Daly AK. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 1999, 8: 289-92. PMID: 10207630WelfareMMonesola AdeokunABassendineMFDalyAK.Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev1999, 8: 289-92. PMID: 10207630Search in Google Scholar
Jang Y, Lu SA, Chen ZP, Ma J, Xu CQ, Zhang CZ, et al. Genetic polymorphisms of CCND1 and PTEN in progression of esophageal squamous carcinoma. Genet Mol Res 2013; 12: 6685-91. doi: 10.4238/2013JangYLuSAChenZPMaJXuCQZhangCZGenetic polymorphisms of CCND1 and PTEN in progression of esophageal squamous carcinoma. Genet Mol Res2013; 12: 6685-91. doi: 10.4238/2013Open DOISearch in Google Scholar
Potęga A. Glutathione-mediated conjugation of anticancer drugs: An overview of reaction mechanisms and biological significance for drug detoxification and bioactivation. Molecules 2022, 27: 5252. doi: 10.3390/molecules27165252PotęgaA.Glutathione-mediated conjugation of anticancer drugs: An overview of reaction mechanisms and biological significance for drug detoxification and bioactivation. Molecules2022, 27: 5252. doi: 10.3390/molecules27165252Open DOISearch in Google Scholar
Deng N, Zhou H, Fan H, Yuan Y. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget 2017, 8: 110635. doi: 10.18632/oncotarget.22372DengNZhouHFanHYuanY.Single nucleotide polymorphisms and cancer susceptibility. Oncotarget2017, 8: 110635. doi: 10.18632/oncotarget.22372Open DOISearch in Google Scholar
Deng X, Hou J, Deng Q, Zhong Z. Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms. World J Surg Oncol 2020, 18: 1-10. doi: 10.1186/s12957-020-02103-3DengXHouJDengQZhongZ.Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms. World J Surg Oncol2020, 18: 1-10. doi: 10.1186/s12957-020-02103-3Open DOISearch in Google Scholar
Farmohammadi A, Arab-Yarmohammadi V, Ramzanpour R. Association analysis of rs1695 and rs1138272 variations in GSTP1 gene and breast cancer susceptibility. Asian Pac J Cancer Prev 2020; 21: 1167. doi: 10.31557/APJCP.2020.21.4.1167FarmohammadiAArab-YarmohammadiVRamzanpourR.Association analysis of rs1695 and rs1138272 variations in GSTP1 gene and breast cancer susceptibility. Asian Pac J Cancer Prev2020; 21: 1167. doi: 10.31557/APJCP.2020.21.4.1167Open DOISearch in Google Scholar
Kudhair BK, Abdulridha FM, Hussain GM, Lafta IJ, Alabid NN. The association of combined GSTM1, GSTT1, and GSTP1 genetic polymorphisms with lung cancer risk in male Iraqi Waterpipe Tobacco (Nargila) smokers. Cancer Epidemiol 2024; 93: 102689. doi: 10.1016/j.canep.2024.102689.KudhairBKAbdulridhaFMHussainGMLaftaIJAlabidNN.The association of combined GSTM1, GSTT1, and GSTP1 genetic polymorphisms with lung cancer risk in male Iraqi Waterpipe Tobacco (Nargila) smokers. Cancer Epidemiol2024; 93: 102689. doi: 10.1016/j.canep.2024.102689.Open DOISearch in Google Scholar
Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 275-80. doi: 10.1093/carcin/19.2.275WatsonMAStewartRKSmithGBMasseyTEBellDA.Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis1998; 19: 275-80. doi: 10.1093/carcin/19.2.275Open DOISearch in Google Scholar
Terrazzino S, La Mattina P, Masini L, Caltavuturo T, Gambaro G, Canonico PL, et al. Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiother Oncol 2012; 103: 199-205. doi: 10.1016/j.radonc.2011.12.002TerrazzinoSLa MattinaPMasiniLCaltavuturoTGambaroGCanonicoPLCommon variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiother Oncol2012; 103: 199-205. doi: 10.1016/j.radonc.2011.12.002Open DOISearch in Google Scholar
Osti MF, Nicosia L, Agolli L, Gentile G, Falco T, Bracci S, et al. Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy. Am J Clin Oncol 2017; 40: 535-42. doi: 10.1097/COC.0000000000000182OstiMFNicosiaLAgolliLGentileGFalcoTBracciSPotential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy. Am J Clin Oncol2017; 40: 535–42. doi: 10.1097/COC.0000000000000182Open DOISearch in Google Scholar
Rodrigues-Fleming GH, Fernandes GMM, Russo A, Biselli-Chicote PM, Netinho JG, Pavarino É, et al. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer. World J Gastroenterol 2018; 24: 4462. doi: 10.3748/wjg.v24.i39.4462Rodrigues-FlemingGHFernandesGMMRussoABiselli-ChicotePMNetinhoJGPavarinoÉMolecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer. World J Gastroenterol2018; 24: 4462. doi: 10.3748/wjg.v24.i39.4462Open DOISearch in Google Scholar
Khabaz MN, Al-Maghrabi JA, Nedjadi T, Gar MA, Bakarman M, Gazzaz ZJ, et al. Does Val/Val genotype of GSTP1 enzyme affects susceptibility to colorectal cancer in Saudi Arabia. Neuro Endocrinol Lett 2016; 37: 46-52. PMID: 26994385KhabazMNAl-MaghrabiJANedjadiTGarMABakarmanMGazzazZJDoes Val/Val genotype of GSTP1 enzyme affects susceptibility to colorectal cancer in Saudi Arabia. Neuro Endocrinol Lett2016; 37: 46-52. PMID: 26994385Search in Google Scholar
Gorukmez O, Yakut T, Gorukmez O, Sag SO, Topak A, Sahinturk S, et al. Glutathione S-transferase T1, M1 and P1 genetic polymorphisms and susceptibility to colorectal cancer in Turkey. Asian Pac J Cancer Prev 2016; 17: 3855-9. PMID: 27644629GorukmezOYakutTGorukmezOSagSOTopakASahinturkSGlutathione S-transferase T1, M1 and P1 genetic polymorphisms and susceptibility to colorectal cancer in Turkey. Asian Pac J Cancer Prev2016; 17: 3855-9. PMID: 27644629Search in Google Scholar
Vlaykova T, Miteva L, Gulubova M, Stanilova S. Ile 105 Val GSTP1 polymorphism and susceptibility to colorectal carcinoma in Bulgarian population. Int J Colorectal Dis 2007; 22: 1209-15. doi: 10.1007/s00384-007-0305-zVlaykovaTMitevaLGulubovaMStanilovaS.Ile 105 Val GSTP1 polymorphism and susceptibility to colorectal carcinoma in Bulgarian population. Int J Colorectal Dis2007; 22: 1209-15. doi: 10.1007/s00384-007-0305-zOpen DOISearch in Google Scholar
Puerta-García E, Urbano-Pérez D, Carrasco-Campos MI, Pérez-Ramírez C, Segura-Pérez A, Calleja-Hernández, et al. Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. Surg Oncol 2020; 35: 388-98. doi: 10.1016/j.suronc.2020.09.016Puerta-GarcíaEUrbano-PérezDCarrasco-CamposMIPérez-RamírezCSegura-PérezACalleja-HernándezEffect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. Surg Oncol2020; 35: 388-98. doi: 10.1016/j.suronc.2020.09.016Open DOISearch in Google Scholar
Klusek J, Nasierowska-Guttmejer A, Kowalik A, Wawrzycka I, Lewitowicz P, Chrapek M, et al. GSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers. Oncotarget 2018; 9: 21224. doi: 10.18632/oncotarget.25031KlusekJNasierowska-GuttmejerAKowalikAWawrzyckaILewitowiczPChrapekMGSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers. Oncotarget2018; 9: 21224. doi: 10.18632/oncotarget.25031Open DOISearch in Google Scholar
Liu J, Pan Y, Liu Y, Wei W, Hu X, Xin W, et al. The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets. J Cell Physiol 2023; 238: 1693-715. doi: 10.1002/jcp.31053LiuJPanYLiuYWeiWHuXXinWThe regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets. J Cell Physiol2023; 238: 1693-715. doi: 10.1002/jcp.31053Open DOISearch in Google Scholar
Papa A, Pandolfi P. The PTEN–PI3K axis in cancer. Biomolecules 2019; 9: 153. doi: 10.3390/biom9040153PapaAPandolfiP.The PTEN–PI3K axis in cancer. Biomolecules2019; 9: 153. doi: 10.3390/biom9040153Open DOISearch in Google Scholar
Jang HY, Kim DH, Lee HJ, Kim WD, Kim SY, Hwang JJ, et al. Scheduledependent synergistic effects of 5-fluorouracil and selumetinib in KRAS or BRAF mutant colon cancer models. Biochem Pharmacol 2019; 160: 110-20. doi: 10.1016/j.bcp.2018.12.017JangHYKimDHLeeHJKimWDKimSYHwangJJScheduledependent synergistic effects of 5-fluorouracil and selumetinib in KRAS or BRAF mutant colon cancer models. Biochem Pharmacol2019; 160: 110-20. doi: 10.1016/j.bcp.2018.12.017Open DOISearch in Google Scholar
Xu X, Chen G, Wu L, Liu L. Association of genetic polymorphisms in PTEN and additional gene–gene interaction with risk of esophageal squamous cell carcinoma in Chinese Han population. Dis Esophagus, 2016; 29: 944-9. doi: 10.1111/dote.12428XuXChenGWuLLiuL.Association of genetic polymorphisms in PTEN and additional gene–gene interaction with risk of esophageal squamous cell carcinoma in Chinese Han population. Dis Esophagus, 2016; 29: 944-9. doi: 10.1111/dote.12428Open DOISearch in Google Scholar
Hassan MH, Nassar AY, Meki AMA, Nasser SA, Bakri AH, Radwan E. Pharmacogenetic study of phosphatase and tensin homolog polymorphism (rs701848) in childhood epilepsy: relation to circulating Wnt signaling. Neurol Res 2024; 46: 99-110. doi: 10.1080/01616412.2023.2257465HassanMHNassarAYMekiAMANasserSABakriAHRadwanE.Pharmacogenetic study of phosphatase and tensin homolog polymorphism (rs701848) in childhood epilepsy: relation to circulating Wnt signaling. Neurol Res2024; 46: 99-110. doi: 10.1080/01616412.2023.2257465Open DOISearch in Google Scholar
Shek D, Read SA, Ahlenstiel G, Piatkov I. Pharmacogenetics of anticancer monoclonal antibodies. Cancer Drug Resistance 2019; 2: 69-81. doi: 10.20517/cdr.2018.20ShekDReadSAAhlenstielGPiatkovI.Pharmacogenetics of anticancer monoclonal antibodies. Cancer Drug Resistance2019; 2: 69-81. doi: 10.20517/cdr.2018.20Open DOISearch in Google Scholar